# Assessing Lung Involvement in Paediatric Rheumatic Diseases: A Retrospective Evaluation of the Limitations of Spirometry

**Authors:** Spyridon Prountzos, Kyveli Chiotopoulou, Katerina Kourtesi, Evdoxia Sapountzi, Dafni Moriki, Elpiniki Kartsiouni, Euthymia Alexopoulou, Konstantinos Douros, Lampros Fotis

PMC · DOI: 10.31138/mjr.020325.pae · Mediterranean Journal of Rheumatology · 2025-08-18

## TL;DR

This study shows that spirometry is not reliable for detecting lung issues in children with rheumatic diseases, suggesting that CT scans are more accurate despite radiation risks.

## Contribution

The study quantifies spirometry's low sensitivity in detecting lung involvement in pediatric rheumatic diseases using HRCT as a reference.

## Key findings

- Only 29.4% of patients with lung involvement had abnormal spirometry results.
- Seventy-seven percent of patients had technically acceptable spirometry, but it missed most HRCT-detected lung abnormalities.
- HRCT remains the preferred diagnostic method despite radiation concerns.

## Abstract

Lung involvement in paediatric rheumatic diseases significantly impacts morbidity and mortality. High-resolution computed tomography (HRCT) is a sensitive diagnostic tool but raises concerns about radiation exposure. Spirometry, a non-invasive and accessible test, is often used to assess pulmonary function, but its accuracy in detecting lung disease in newly diagnosed pediatric rheumatic conditions remains uncertain. This study evaluates spirometry’s reliability, using HRCT as the reference standard.

Patients suspected of lung involvement due to respiratory symptoms or disease prevalence underwent HRCT and pulmonary assessment. A retrospective review of HRCT scans was conducted for 22 pediatric patients diagnosed with rheumatic disease (January 2021–December 2023), all of whom had pathological findings. HRCT was performed using a paired end-inspiratory and forced-expiratory protocol with 1-mm collimation. Radiological findings, including parenchymal opacities, ground-glass opacities, reticular patterns, honeycombing, parenchymal bands, bronchiectasis, peribronchial wall thickening, and air trapping, were assessed. Spirometric values—percent predicted Forced Expiratory Volume in 1 second (ppFEV1), Forced Vital Capacity (ppFVC), and FEV1/FVC ratio—were collected for patients with acceptable flow-volume curves.

Seventeen of 22 patients (77.3%) had technically acceptable spirometry. Compared to HRCT, spirometry demonstrated a sensitivity of 29.4%.

Despite its excellent positive predictive value, spirometry’s low sensitivity suggests it may miss early lung involvement in paediatric rheumatic diseases. HRCT remains the preferred diagnostic tool to ensure accurate detection and management, despite radiation concerns.

## Full-text entities

- **Diseases:** Rheumatic Diseases (MESH:D012216), bronchiectasis (MESH:D001987), Lung Involvement (MESH:D008171)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12536758/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12536758/full.md

---
Source: https://tomesphere.com/paper/PMC12536758